Peter Donnelly
Born in 1965. Chairman of the Board since 2021.
Experience and relevant training
Dr Peter Donnelly has a Bachelor of Engineering and a PhD degree in Electronics and Intelligent Adaptive Algorithms from Ulster University. Over the past 29 years Peter Donnelly has worked for blue-chip companies, new start businesses and research organisations in various industries. In addition to being the founder and CEO of BioBusiness Ltd, Peter has founded two medical device companies in the cardio-respiratory area and is the CEO and founder of Tapa Healthcare DAC. Peter is co-founder of MedZone Solutions. Furthermore, Peter has been involved in Northern Ireland government initiatives such as skills development and strategic economic foresight studies as well as operated as a UK Sector specialist to inform Government Departments and Agencies in Westminster. Peter has been director in PMD Device Solutions Limited since 2014.
Ongoing appointments
Other current appointments: Director and CEO of Tapa Healthcare DAC and director of MedZone Solutions.
Holdings in the Company
Independent in relation to the company and its executive management and independent of the company’s main owners.
Christer Ahlberg
Born in 1971. Board member since 2021.
Experience and relevant training
Christer Ahlberg holds a degree in economics from Örebro University. Christer has previously acted as CEO and Group CEO of Sedana Medical AB (publ). He has previous experience from the pharmaceutical industry as, inter alia, CEO within the Unimedic Group and CEO of Eisai AB. Christer has more than 10 years of experience of top positions in retail, marketing and market access in the pharmaceutical industry from companies such as AstraZeneca, Meda and Wyeth.
Ongoing appointments
Director of FrostPharma AB and Prooxpharma AB, CEO of Cinclus Pharma Holding AB (pubL), CEO and deputy board member in Waxholm by the sea aktiebolag.
Holdings in the Company
Dependent in relation to the company and its executive management and dependent of the company’s main owners.
Magnus Christensen
Born in 1974. Board member since 2021.
Experience and relevant training
Magnus Christensen has a Bachelor of Science degree from University of East Anglia. Christensen has extensive CFO experience of listed companies. Magnus has held the position of CFO at several large companies, including O’Leary’s Trademark AB and Rebtel AB. Additionally, he has been Head of Business Control at ICA Sverige AB.
Ongoing appointments
CFO Medivir AB
Holdings in the Company
Independent in relation to the company and its executive management and independent of the company’s main owners.
Myles Murray
Born in 1986. Board member since 2021.
Experience and relevant training
CEO and Founder of PMD. Myles Murray has a Bachelor of Engineering (Honours) degree in Mechanical Engineering from Cork Institute of Technology, as well as a post graduate certificate in Capital Markets. Myles has extensive experience within the medical technology industry and is a member of the Irish Medtech Association and a fellow of NHS Innovation Accelerator. Myles has been the CEO of PMD Device Limited since 2011.
Ongoing appointments
None
Holdings in the Company
Dependent in relation to the company and its executive management and dependent of the company’s main owners.
Anne Dorney
Born in 1958. Board member since 2021.
Experience and relevant training
CCO and Executive Director of PMD. Anne Dorney is a Member of Compliance Institute Ireland. A Qualified lender with the Institute of Banking Ireland. Former Bank Manager with AIB Bank. Anne has extensive management experience in Financials, Compliance, HR, Operations, Audit & Business Development, Business planning and Strategy. Former consultant and mentor to several start-up companies and businesses. Anne held the position of CFO in PMD Device Solutions Limited from 2013 to 2021.
Ongoing appointments
None
Holdings
Dependent in relation to the company and its executive management and dependent of the company’s main owners.